District of Columbia · Gabapentin use and a claim for memory loss
Gabapentin use and a claim for memory loss in District of Columbia
See If You Qualify
Free · No obligation · About 2 minutes
| Filing deadline | 3 years from discovery of injuryD.C. Code § 12-301(a)(8) |
|---|
Deadlines vary with the facts of each case. A lawyer can confirm yours.
Updated
01 · Your filing deadline
What is the deadline in District of Columbia?
District of Columbia: 3 years for personal injury (D.C. Code § 12-301(a)(8)). Discovery rule applies — limitations begin when the plaintiff knew or should have known of the injury and its connection to the product. A lawyer can confirm yours.
Source: D.C. Code § 12-301(a)(8)
Deadlines vary; a lawyer can confirm yours. An older diagnosis or a past filing window does not, by itself, establish whether you have a claim.

02 · Where cases are heard
Where would my case be heard?
The District of Columbia is a strategically significant jurisdiction for gabapentin litigation due to the concentration of federal regulatory agencies — the FDA, DEA, and FTC — that oversee pharmaceutical safety and marketing. DC's population of 700,000 has moderate gabapentin prescribing rates relative to population, but the district's legal significance extends far beyond local prescribing. Federal regulatory records, congressional testimony, and FDA correspondence regarding gabapentin safety are most accessible through DC-based litigation. The district's courts are experienced in complex pharmaceutical cases, and DC's consumer protection laws provide additional legal theories beyond traditional product liability.
DC gabapentin cases are filed in the U.S. District Court for the District of Columbia or in DC Superior Court. The federal court has extensive experience with pharmaceutical and regulatory litigation. DC follows contributory negligence with the last clear chance doctrine, which can bar plaintiff recovery if the plaintiff was negligent — though this is rarely an issue in pharmaceutical product liability cases. DC's Consumer Protection Procedures Act provides additional theories including deceptive trade practices related to gabapentin marketing.
How this works nationally
For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for District of Columbia.
What happens when I check?
You answer a few short questions about what happened. If you send them, your answers are kept on file. If a participating law firm takes these cases, it may contact you. People's Justice is not a law firm.
Live in District of Columbia? Read what applies in your state.
Register your interest. If a participating law firm takes these cases, it may contact you.
Register your interestSources
- D.C. Code § 12-301(a)(8)